Page last updated: 2024-10-19

thioctic acid and HIV-Associated Lipodystrophy Syndrome

thioctic acid has been researched along with HIV-Associated Lipodystrophy Syndrome in 1 studies

Thioctic Acid: An octanoic acid bridged with two sulfurs so that it is sometimes also called a pentanoic acid in some naming schemes. It is biosynthesized by cleavage of LINOLEIC ACID and is a coenzyme of oxoglutarate dehydrogenase (KETOGLUTARATE DEHYDROGENASE COMPLEX). It is used in DIETARY SUPPLEMENTS.

HIV-Associated Lipodystrophy Syndrome: Defective metabolism leading to fat maldistribution in patients infected with HIV. The etiology appears to be multifactorial and probably involves some combination of infection-induced alterations in metabolism, direct effects of antiretroviral therapy, and patient-related factors.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Milazzo, L1
Menzaghi, B1
Caramma, I1
Nasi, M1
Sangaletti, O1
Cesari, M1
Zanone Poma, B1
Cossarizza, A1
Antinori, S1
Galli, M1

Trials

1 trial available for thioctic acid and HIV-Associated Lipodystrophy Syndrome

ArticleYear
Effect of antioxidants on mitochondrial function in HIV-1-related lipoatrophy: a pilot study.
    AIDS research and human retroviruses, 2010, Volume: 26, Issue:11

    Topics: Absorptiometry, Photon; Acetylcarnitine; Adult; Antioxidants; Body Composition; Breath Tests; Carboh

2010